Skip to content

Impact of Nutrition Intervention on HIV/AIDS Infected Patients

Phase 3 Study That Assesses the Impact of a Nutrition Intervention on HIV/AIDS Infected Patients: Kingston, Jamaica

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01171495
Acronym
INI
Enrollment
121
Registered
2010-07-28
Start date
2008-04-30
Completion date
2009-08-31
Last updated
2010-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Immune Deficiency Syndrome (AIDS), Human Immunodeficiency Virus (HIV)

Keywords

HIV/AIDS, Nutrition Therapy, Dietary Supplement, Antioxidant, Immunity, CD4 count, Anthropometry, Body Mass Index

Brief summary

Intervention to investigate the efficacy of a nutritional supplement among ARV-naïve, asymptomatic HIV positive patients with a CD4 count in the range 300-550 cells/ul.

Detailed description

To investigate the efficacy of a nutritional supplement among ARV-naïve, asymptomatic HIV positive patients with a CD4 count in the range 300-550 cells/ul. A total of 120 participants will be stratified by age and gender and randomly assigned to two treatment arms. Sixty (60) participants will be assigned to receive dietary counselling and a multivitamin/mineral supplement, with sixty (60) additionally receiving an oral Medical Nutritional Supplement (MNS). Participants will be followed for six months post-randomization: at baseline, 3 months and 6 months. The principal outcome measure is Body Mass Index, used as a proxy for 'nutritional status'. Secondary outcome measures include immune status and antioxidant status.

Interventions

DIETARY_SUPPLEMENTTheragran-M; Ensure Plus

Theragran-M: One tablet daily for 6-months. Ensure Plus: One 8 fl.oz. bottle daily for 6-months. Nutritional counselling: at baseline, and at monthly follow-up visits.

DIETARY_SUPPLEMENTTheragran-M

Theragran-M: One tablet daily for 6-months. Nutritional counselling: at baseline and at monthly follow-up visits.

Sponsors

The University of The West Indies
CollaboratorOTHER
Caribbean Health Research Council
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* HIV positive individuals in the age range 18 to 50 years. * Individuals whose CD4 count was between 300-550 cells/uL. * Individuals who met the study criteria and were interested in being enrolled. * Individuals not on ARV therapy. * Women who were not pregnant.

Exclusion criteria

* On the clinician's advice, individuals could be excluded from enrollment. * Individuals who were unable to carry out the study intervention e.g. homeless, impaired mental state etc. * Individuals who were unlikely to complete follow-up based on pre-enrolment assessment.

Design outcomes

Primary

MeasureTime frameDescription
Effects of nutritional intervention on anthropometry in HIV infected individuals.6 monthsBody Mass Index

Secondary

MeasureTime frameDescription
Effects of nutritional intervention on the clinical and immune status in HIV infected individuals.6 monthsImmune status (CD4 cell count, total lymphocyte count), antioxidant status.

Countries

Jamaica

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026